Skip to main content

Cardlytics Inc

For the period ended Dec 31, 2023. Filed Mar 14, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 14, 2024

CDLX$1.82-6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Cardlytics, Inc.
March 14, 2024By:/s/ Karim Temsamani
Karim Temsamani
Chief Executive Officer
(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Karim TemsamaniChief Executive Officer and DirectorMarch 14, 2024
Karim Temsamani(Principal Executive Officer)
/s/ Alexis DeSienoChief Financial OfficerMarch 14, 2024
Alexis DeSieno(Principal Financial and Accounting Officer)
/s/ John KlinckBoard ChairpersonMarch 14, 2024
John Klinck
/s/ Andre FernandezDirectorMarch 14, 2024
Andre Fernandez
/s/ Jon FrancisDirectorMarch 14, 2024
Jon Francis
/s/ Scott HillDirectorMarch 14, 2024
Scott Hill
/s/ Jessica JensenDirectorMarch 14, 2024
Jessica Jensen
/s/ Aimée LapicDirectorMarch 14, 2024
Aimée Lapic
/s/ Alex MishurovDirectorMarch 14, 2024
Alex Mishurov
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.